GB2453901A - Protein solubilisation - Google Patents
Protein solubilisation Download PDFInfo
- Publication number
- GB2453901A GB2453901A GB0902200A GB0902200A GB2453901A GB 2453901 A GB2453901 A GB 2453901A GB 0902200 A GB0902200 A GB 0902200A GB 0902200 A GB0902200 A GB 0902200A GB 2453901 A GB2453901 A GB 2453901A
- Authority
- GB
- United Kingdom
- Prior art keywords
- solution
- protein solubilisation
- protein
- solubilisation
- maintaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract description 4
- 102000004169 proteins and genes Human genes 0.000 title abstract description 4
- 238000000034 method Methods 0.000 abstract description 2
- 238000012916 structural analysis Methods 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to a method of identifying optimal or desirable conditions for maintaining a selected protein in solution for enabling proteins to be kept in solution at high enough concentrations for structural analysis and the like.
Description
GB 2453901 A continuation (56) cont ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, Vol. 60, 2004, J Janarik et al, "Optimum solubility (OS) screening: an efficient method to optimize buffer conditions for homogeneity and crystallization of proteins.", 1670-1673
BIOCHIMICA ET BIOPHYSICA ACTA -
BIOMEMBRANES, Vol. 1508, 2000, M Le Maire et al, "Interaction of membrane proteins and lipids with solubilizing detergents", 86-111
(58) Field of Search by ISA:
INT CL GO1N Other: ONLINE: EPO-Internal, WPI Data, BIOSIS,
EM BASE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0615312.6A GB0615312D0 (en) | 2006-08-02 | 2006-08-02 | Protein Solubilisation |
PCT/GB2007/002914 WO2008015419A2 (en) | 2006-08-02 | 2007-08-01 | Protein solubilisation |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0902200D0 GB0902200D0 (en) | 2009-03-25 |
GB2453901A true GB2453901A (en) | 2009-04-22 |
GB2453901B GB2453901B (en) | 2011-07-13 |
Family
ID=37027070
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0615312.6A Ceased GB0615312D0 (en) | 2006-08-02 | 2006-08-02 | Protein Solubilisation |
GB0902200A Expired - Fee Related GB2453901B (en) | 2006-08-02 | 2007-08-01 | Protein solubilisation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0615312.6A Ceased GB0615312D0 (en) | 2006-08-02 | 2006-08-02 | Protein Solubilisation |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB0615312D0 (en) |
WO (1) | WO2008015419A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100014674A (en) | 2007-03-29 | 2010-02-10 | 아보트 러보러터리즈 | Crystalline anti-human il-12 antibodies |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
US8557253B2 (en) * | 2009-10-07 | 2013-10-15 | Sanofi Pasteur Sa | Stabilizing excipient for inactivated whole virus vaccine |
CN107290545B (en) * | 2017-06-19 | 2019-01-18 | 威海威仕泰医疗科技有限公司 | A kind of stable β2-microglobulin solution, preparation method and application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1668358B1 (en) * | 2003-08-05 | 2014-12-10 | The Research Foundation of State University of New York | Reconstitution medium for protein and peptide formulations |
-
2006
- 2006-08-02 GB GBGB0615312.6A patent/GB0615312D0/en not_active Ceased
-
2007
- 2007-08-01 GB GB0902200A patent/GB2453901B/en not_active Expired - Fee Related
- 2007-08-01 WO PCT/GB2007/002914 patent/WO2008015419A2/en active Application Filing
Non-Patent Citations (6)
Title |
---|
ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, Vol. 60, 2004 , J Janarik et al, "Optimum solubility (OS) screening: an efficient method to optimize buffer conditions for homogeneity and crystallization of proteins.", 1670-1673 * |
ANALYTICAL BIOCHEMISTRY, Vol. 316, 2003, S Bondos et al, "Detection and prevention of protein aggregation before, during, and after purification.", 223-231 * |
BIOCHIMICA ET BIOPHYSICA ACTA - BIOMEMBRANES, Vol. 1508, 2000, M Le Maire et al, "Interaction of membrane proteins and lipids with solubilizing detergents", 86-111 * |
JOURNAL OF CHROMATOGRAPHY, Vol. 443, 988, S Welling-Wester et al, "Effect of detergents on the structure of integral membrane proteins of Sendai virus studied with size-exclusion high-performance liquid chromatography and monoclonal antibodies.", 255-266 * |
MOLECULAR PROBES - INVITROGEN DETECTION TECHNOLOGIES, [Online] 8 July 2005, Anonymous, "EZQ Protein Quantitation Kit (R33200)" pages 1-4. Retrieved from the Internet URL: http://wolfson.huji.ac.il/purification/PDF/Protein_Quantification/MOLECULAR_PROBES_EZQProtQuantKit.pdf * |
STRUCTURE, Vol. 14, 2006, T Kawate et al, "Fluorescence-Detection Size-Exclusion Chromatography for Precrystallization Screening of Integral Membrane Proteins", 673-681 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008015419A3 (en) | 2008-03-20 |
GB0902200D0 (en) | 2009-03-25 |
GB2453901B (en) | 2011-07-13 |
GB0615312D0 (en) | 2006-09-13 |
WO2008015419A2 (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tie et al. | Structural and functional insights into enzymes of the vitamin K cycle | |
Wu et al. | Crystal Structure of Human Spermine Synthase: IMPLICATIONS OF SUBSTRATE BINDING AND CATALYTIC MECHANISM*♦ | |
Bos et al. | A bipartite autoinhibitory region within the B-domain suppresses function in factor V | |
Lin et al. | Purification of membrane proteins | |
JP4836786B2 (en) | Compositions and methods for stable isotope labeling of biological compounds | |
US20210214401A1 (en) | Manufacturing method of nanodisc comprising an olfactory receptor protein and nanodisc comprising an olfactory receptor protein manufactured by the same | |
Stallings et al. | Nuclear translocation of phospholipase C-δ1 is linked to the cell cycle and nuclear phosphatidylinositol 4, 5-bisphosphate | |
Suzuki et al. | Methyl-selective isotope labeling using α-ketoisovalerate for the yeast Pichia pastoris recombinant protein expression system | |
JP6728294B2 (en) | A new method for protein purification. | |
GB2453901A (en) | Protein solubilisation | |
WO2008030613A3 (en) | Hybrid suppressor trna for vertebrate cells | |
US20240310391A1 (en) | Hdl-associated protein extraction and detection | |
Amorim et al. | New insights on moojase, a thrombin-like serine protease from Bothrops moojeni snake venom | |
Chen et al. | Identification of the abundant hydroxyproline-rich glycoproteins in the root walls of wild-type Arabidopsis, an ext3 mutant line, and its phenotypic revertant | |
Roy | Membrane preparation and solubilization | |
de Jong et al. | Purification and substrate specificity of transglutaminases from blood and Streptoverticillium mobaraense | |
Tian et al. | Molecular insights into the mode of action of antibacterial peptides derived from chicken plasma hydrolysates | |
Wong et al. | A carboxy-terminal affinity tag for the purification and mass spectrometric characterization of integral membrane proteins | |
Haksar et al. | Comparison of the Ca++ requirement for the steroidogenic effect of ACTH and dibutyryl cyclic AMP in rat adrenal cell suspensions | |
Soupene et al. | ATP8A1 activity and phosphatidylserine transbilayer movement | |
Martin et al. | [43] Dissociation and reassociation of ribosomes from eukaryotic cells | |
Schenk et al. | Lipoprotein-induced phenoloxidase-activity in tarantula hemocyanin | |
Plíhal et al. | Large propeptides of fungal β-N-acetylhexosaminidases are novel enzyme regulators that must be intracellularly processed to control activity, dimerization, and secretion into the extracellular environment | |
Kawaguchi et al. | Molecular co-evolution of a protease and its substrate elucidated by analysis of the activity of predicted ancestral hatching enzyme | |
Hashimoto et al. | Development of a large-scale (50 L) apparatus for ampholyte-free isoelectric focusing (autofocusing) of peptides in enzymatic hydrolysates of food proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20120801 |